Healthcare Equipment and Supplies
Company Overview of ReVascular Therapeutics, Inc.
Revascular Therapeutics, Inc. manufactures arterial occlusion treatment equipment. It develops percutaneous medical devices to reopen occluded vessels. The company develops technology for the intravascular treatment of complex lesions and total occlusions. The company was formerly known as Norborn Medical, Inc. The company was incorporated in 1999 and is headquartered in Sunnyvale, California. As of February 15, 2011, ReVascular Therapeutics, Inc. operates as a subsidiary of Boston Scientific Corporation.
766 Palomar Avenue
Sunnyvale, CA 94085
Founded in 1999
Key Executives for ReVascular Therapeutics, Inc.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact ReVascular Therapeutics, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.